Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
50.20    0.50 (1.01%)
Bid:
49.65
Ask:
50.20
Spread: 0.55 (1.108%)
Market Cap: £199.85m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Scrip Dividend Reference Share Price

16 Apr 2026 14:59

RNS Number : 8131A
CLS Holdings PLC
16 April 2026
 
 

CLS Holdings plc

("CLS" or the "Company")

Scrip Dividend Reference Share Price - 2025 Final Dividend

On 13 March 2026 the Company announced its final results for the year ending 31 December 2025 and that it would be recommending a 2025 final dividend of 2.7 pence per ordinary share of 2.5 pence each (a "Share"), fully paid as a Property Income Distribution (the "2025 Final Dividend").

Conditional upon the requisite resolutions being approved by shareholders at the 2026 Annual General Meeting, an enhanced scrip dividend is being offered to shareholders in respect of the 2025 Final Divided, as an alternative to the receiving the 2025 Final Dividend in cash (the "Enhanced Scrip Dividend Alternative").

If the resolutions required to offer the Enhanced Scrip Dividend Alternative are approved by the requisite majority at the 2026 Annual General Meeting, Shareholders who elect to participate in the Enhanced Scrip Dividend Alternative would receive new Shares with a value calculated on the basis of a discount of 5% to the Scrip Reference Share Price of 48.2 pence per Share.

This Scrip Reference Share Price is calculated as the average of the middle market quotations of a Share, derived from the London Stock Exchange Daily Official List, for the five Business Days starting on the day the Shares are first quoted ex-dividend, being from 9 April 2025 to 15 April 2025 (inclusive).

The deadline for applications for the Enhanced Scrip Dividend Alternative in respect of the 2025 Final Dividend is 5 pm (London time) on 30 April 2026. More details of the Enhanced Scrip Dividend Alternative, including details on how to elect to receive the Enhanced Scrip Dividend Alternative, are available on the Company's website at www.clsholdings.com.

 

-ends-

For further information, please contact:

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

David Fuller, Company Secretary

+44 (0)20 7582 7766

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVAKABPNBKDOQD
Date   Source Headline
6th May 20206:15 pmRNSDirector/PDMR Shareholding
1st May 202012:13 pmRNSDirector/PDMR Shareholding
29th Apr 202011:21 amRNSDisclosure of rights attached to equity shares
23rd Apr 20205:16 pmRNSResult of AGM
23rd Apr 202012:14 pmRNSResult of AGM
23rd Apr 202012:12 pmRNSAppointment of Senior Independent Director
14th Apr 20203:24 pmRNSDirector/PDMR Shareholding
9th Apr 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSTrading Statement
6th Apr 20205:36 pmRNSDirector/PDMR Shareholding
1st Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20206:06 pmRNSDirector/PDMR Shareholding
24th Mar 20201:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:42 pmRNSAnnual Financial Report
23rd Mar 20203:09 pmRNSDirector/PDMR Shareholding
20th Mar 20205:14 pmRNSDirector/PDMR Shareholding
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 20208:24 amRNSDirector/PDMR Shareholding
12th Mar 20205:22 pmRNSDirector/PDMR Shareholding
10th Mar 20208:53 amRNSDirector/PDMR Shareholding
6th Mar 20205:31 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
24th Feb 20207:00 amRNSNotice of Results
17th Feb 202010:26 amRNSHolding(s) in Company
12th Feb 20202:14 pmRNSDirector/PDMR Shareholding
4th Feb 20206:14 pmRNSNotification of change in a Director's details
23rd Jan 20205:13 pmRNSDirector/PDMR Shareholding
14th Jan 20204:47 pmRNSDirector/PDMR Shareholding
8th Jan 20207:00 amRNSAcquisition
31st Dec 20197:00 amRNSSale of the UK regional office portfolio
11th Dec 20195:16 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSTrading Statement
20th Nov 20197:00 amRNSAppointment of independent Non-Executive Director
13th Nov 20197:00 amRNSAcquisition
8th Nov 20194:07 pmRNSDirector/PDMR Shareholding
17th Oct 20194:53 pmRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSAcquisition
11th Oct 20195:03 pmRNSDirector/PDMR Shareholding
3rd Oct 20197:00 amRNSAcquisition
6th Sep 20195:41 pmRNSDirector/PDMR Shareholding
3rd Sep 20197:00 amRNSShareholding in Catena AB
2nd Sep 20194:31 pmRNSShareholding in Catena AB
14th Aug 20194:05 pmRNSDirector/PDMR Shareholding
14th Aug 20197:00 amRNSHalf-year Report
8th Aug 20199:09 amRNSDirector/PDMR Shareholding
5th Aug 20195:06 pmRNSNotice of Half Year Results
22nd Jul 20198:03 amRNSCLS announces sales in Munich and Dusseldorf
17th Jul 201911:29 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.